Results per Page:
Biomarkers, tumor markers and tumor boards: What cancer patients need to know
Cancer care is changing — as are the clinical tools, tests and the terms used to diagnose and predict its path and treatment
Two Fred Hutch studies identify pancreatic cancer biomarker driving basal disease
Dr. Sita Kugel’s team recently published two papers identifying a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes apart, but reveals a biological mechanism that could lead to new therapies
Seeking targeted treatments for pancreatic cancer
American Cancer Society fellowship to Dr. Nithya Kartha supports search for vulnerabilities in most aggressive pancreatic tumor subtype
Squelching ovarian cancer: the not-so-silent killer
The search continues for new biomarkers, better outcomes and, yes, cures for this deadly disease
H. pylori test hints at risk factor for stomach cancer
Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer
Glory's gift: Colon cancer patient's enduring legacy
A young woman’s resolve to help find a better way to detect colon cancer led to a years-long relationship between her family and a researcher across the country
Study finds HIV ‘superinfection’ boosts immune response
Findings may provide insight into HIV-vaccine development
Metabolomics expert Raftery joins PHS
Daniel Raftery brings research on cancer metabolism and early detection, and metabolomics profiling services to the Hutchinson Center's proteomics shared resource
Feng receives $1.2 million DOD grant for prostate research
Canary Foundation-supported biostatistician will work on validating biomarkers for prostate cancer prognosis
Improving biomarker development to improve patient outcomes
Amanda Paulovich and colleagues find proof-of-concept study of biomarker development provides roadmap for similar approach in humans
Researchers identify genes that signal oral cancer spread
Discovery could lead to the development of a biomarker-based test in lieu of neck surgery
NCI awards $11.5 million to Fred Hutchinson Cancer Research Center to lead breast cancer research consortium
Projects include developing targeted therapies to treat drug-resistant tumors
T-cell receptors reveal immune system similarities
Finding may lead to new cancer detection, diagnostic and treatment methods
For the first time, researchers identify and isolate adult mammary stem cells in mice
Research implications include breast tissue regeneration and new cancer drug targets
Early markers of ovarian cancer
Public Health Sciences Division finding that biomarkers may show up years ahead of diagnosis is a step forward in early detection efforts
An 'HIV-test' equivalent for early detection of lung cancer
New cancer-screening strategy uses the immune system to signal early signs of disease
Hutchinson Center receives $4.6 million to study biomarkers of common diseases among postmenopausal women
Phase two of Women's Health Initiative supports three new Center research projects